DekaBank Deutsche Girozentrale’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $841K | Sell |
59,800
-4,410
| -7% | -$62K | ﹤0.01% | 898 |
|
|
2025
Q1 | $935K | Buy |
64,210
+4,410
| +7% | +$64.2K | ﹤0.01% | 864 |
|
|
2024
Q4 | $1.22M | Hold |
59,800
| – | – | ﹤0.01% | 839 |
|
|
2024
Q3 | $1.75M | Hold |
59,800
| – | – | ﹤0.01% | 785 |
|
|
2024
Q2 | $1.37M | Sell |
59,800
-4,410
| -7% | -$101K | ﹤0.01% | 828 |
|
|
2024
Q1 | $1.32M | Hold |
64,210
| – | – | ﹤0.01% | 824 |
|
|
2023
Q4 | $1.42M | Hold |
64,210
| – | – | ﹤0.01% | 838 |
|
|
2023
Q3 | $1.36M | Buy |
64,210
+4,410
| +7% | +$93.1K | ﹤0.01% | 820 |
|
|
2023
Q2 | $1.75M | Hold |
59,800
| – | – | ﹤0.01% | 779 |
|
|
2023
Q1 | $1.32M | Hold |
59,800
| – | – | ﹤0.01% | 814 |
|
|
2022
Q4 | $1.67M | Hold |
59,800
| – | – | ﹤0.01% | 760 |
|
|
2022
Q3 | $1.74M | Hold |
59,800
| – | – | 0.01% | 739 |
|
|
2022
Q2 | $1.71M | Hold |
59,800
| – | – | 0.01% | 754 |
|
|
2022
Q1 | $1.94M | Buy |
59,800
+5,400
| +10% | +$175K | ﹤0.01% | 760 |
|
|
2021
Q4 | $2.37M | Buy |
54,400
+1,500
| +3% | +$65.4K | 0.01% | 730 |
|
|
2021
Q3 | $2.61M | Hold |
52,900
| – | – | 0.01% | 669 |
|
|
2021
Q2 | $4.03M | Buy |
52,900
+15,000
| +40% | +$1.14M | 0.01% | 572 |
|
|
2021
Q1 | $2.08M | Hold |
37,900
| – | – | 0.01% | 688 |
|
|
2020
Q4 | $3.22M | Buy |
37,900
+2,100
| +6% | +$178K | 0.01% | 551 |
|
|
2020
Q3 | $1.28M | Buy |
+35,800
| New | +$1.28M | 0.01% | 696 |
|
|
2019
Q3 | – | Sell |
-74,000
| Closed | -$1.52M | – | 1025 |
|
|
2019
Q2 | $1.52M | Buy |
+74,000
| New | +$1.52M | 0.01% | 693 |
|